trending Market Intelligence /marketintelligence/en/news-insights/trending/QJr8Ro_sBGO3pY1SQ_gFgQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Medtronic acquires spinal cord therapy company Stimgenics

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Medtronic acquires spinal cord therapy company Stimgenics

Medtronic PLC said it acquired Stimgenics LLC, a Bloomington, Ill.-based privately held company developing a spinal cord stimulation therapy.

Financial terms of the deal were not disclosed in a Jan. 8 news release.

Stimgenics offers a spinal cord stimulation waveform known as Differential Target Multiplexed spinal cord stimulation. The therapy is delivered through Medtronic's Intellis platform for treating patients with chronic pain.

Dublin-based medical device company Medtronic said the acquisition is expected to be neutral to the company's fiscal 2020 EPS.